XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-based Compensation Expense

The Company recorded stock-based compensation expense in the following expense categories of its consolidated statements of operations (in thousands):

 

 

 

Fiscal Three Months Ended

 

 

Fiscal Six Months Ended

 

 

 

June 30, 2020

 

 

June 29, 2019

 

 

June 30, 2020

 

 

June 29, 2019

 

Cost of revenue

 

$

8

 

 

$

5

 

 

$

12

 

 

$

8

 

Research, development and clinical trials expenses

 

 

129

 

 

 

17

 

 

 

183

 

 

 

33

 

Selling, general and administrative expenses

 

 

494

 

 

 

198

 

 

 

821

 

 

 

236

 

 

 

$

631

 

 

$

220

 

 

$

1,016

 

 

$

277